RIM
JAZZ icon

Ranger Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ranger Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-33
Closed -$5K – 119
2019
Q2 		$5K Hold
33
– – ﹤0.01% 109
2019
Q1 		$5K Buy
33
+9
+38% +$1.17K ﹤0.01% 104
2018
Q4 		$3K Hold
24
– – ﹤0.01% 112
2018
Q3 		$4K Sell
24
-1,400
-98% -$241K ﹤0.01% 106
2018
Q2 		$245K Sell
1,424
-710
-33% -$116K 0.02% 92
2018
Q1 		$322K Hold
2,134
– – 0.02% 94
2017
Q4 		$287K Hold
2,134
– – 0.02% 97
2017
Q3 		$312K Sell
2,134
-2,170
-50% -$328K 0.02% 91
2017
Q2 		$669K Hold
4,304
– – 0.05% 94
2017
Q1 		$625K Sell
4,304
-12,246
-74% -$1.6M 0.05% 95
2016
Q4 		$1.8M Buy
16,550
+40
+0.2% +$4.46K 0.13% 80
2016
Q3 		$2.01M Sell
16,510
-1,230
-7% -$166K 0.14% 74
2016
Q2 		$2.51M Buy
17,740
+60
+0.3% +$8.85K 0.15% 66
2016
Q1 		$2.31M Sell
17,680
-35,199
-67% -$4.38M 0.14% 73
2015
Q4 		$7.43M Sell
52,879
-14,436
-21% -$2M 0.44% 56
2015
Q3 		$8.94M Sell
67,315
-1,172
-2% -$202K 0.5% 54
2015
Q2 		$12.1M Sell
68,487
-2,850
-4% -$512K 0.59% 52
2015
Q1 		$12.3M Buy
71,337
+10,218
+17% +$1.75M 0.6% 53
2014
Q4 		$10M Buy
61,119
+4,180
+7% +$694K 0.51% 53
2014
Q3 		$9.14M Buy
56,939
+24,849
+77% +$3.82M 0.48% 55
2014
Q2 		$4.72M Buy
32,090
+5,600
+21% +$777K 0.23% 67
2014
Q1 		$3.67M Sell
26,490
-1,610
-6% -$242K 0.18% 75
2013
Q4 		$3.56M Sell
28,100
-14,432
-34% -$1.49M 0.17% 69
2013
Q3 		$3.91M Sell
42,532
-1,955
-4% -$158K 0.17% 72
2013
Q2 		$3.06M Buy
+44,487
New +$2.72M 0.15% 78

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ranger Investment Management's JAZZ Position: Q3 2019 in Review

Ranger Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 33 shares — an estimated $5K sold.

Ranger Investment Management first reported a position in JAZZ in Q2 2013 and held it in 25 quarters. The position peaked at $12.3M in Q1 2015. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • Ranger Investment Management reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Ranger Investment Management sold 33 Jazz Pharmaceuticals shares in Q3 2019, an estimated $5K.
  • Ranger Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 25 quarters.
  • Ranger Investment Management's Jazz Pharmaceuticals position peaked at $12.3M in Q1 2015.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Ranger Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.